ABSTRACT Thymosin (fraction 5 and synthetic al peptide) induced prothymocytes in mouse bone marrow and spleen to express terminal deoxynucleotidyl transferase (TdT; DNA nucleotidylexotransferase; nucleosidetriphosphate:DNA deoxynucleotidylexotransferase, EC 2.7.7.31) or Lyt-l+, 2+, 3+ alloantigens (or both) after brief incubation in vitro. Three antigenic phenotypes were generated: (i) TdT+ Lyt+, (ii) TdT-Lyt+, and (iii) TdT+ Lytr. The TdT+ Lyt+ phenotype was expressed by 80% of prothymocytes in bone marrow and 30% of prothymocytes in spleen from normal mice. The TdT-Lyt+ phenotype was expressed by 81% of prothymocytes in bone marrow from athymic mice. More than 80% of TdT+ bone marrow cells from normal and athymic mice expressed Lyt antigens after thymosin treatment. We interpret these observations as suggesting that (i) most TdT+ hemopoietic cells in normal and athymic mice are thymocyte progenitors; (ii) two independent lineages of prothymocytes exist, one that expresses TdT and another that does not; (iii) commitment of prothymocytes to the TdT+ cell pathway is partially regulated by a thymic feedback mechanism; and (iv) the bone marrow preferentially produces TdT+ prothymocytes, whereas the spleen may serve as a repository for TdT-prothymocytes. A model of T-cell development is presented in which the thymus functions as a compound organ to process TdT+ and TdT-thymocyte progenitors and to generate two lines of T cells. Terminal deoxynucleotidyl transferase (TdT; DNA nucleotidylexotransferase; nucleoside triphosphate:DNA deoxynucleotidyltransferase, EC 2.7.7.31) catalyzes deoxynucleoside triphosphate polymerization in the absence ofany known template (1). Its distribution is restricted to immature members of the lymphocyte cell series and to their neoplastic counterparts (2-8).
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Several recent studies using soluble thymus factors strongly suggest that many TdT+ hemopoietic cells are thymocyte progenitors. Silverstone et al. (9, 10) showed that TdT specific activity decreased significantly in suspensions of mouse bone marrow cells that had been incubated in vitro with thymopoietin and then treated with anti-Thy-i serum and complement. Pazmino et al. (11, 12) showed that TdT specific activity in bone marrow from thymectomized or congenitally athymic mice increased significantly after in vivo or in vitro treatment with thymosin. However, it was not possible in these studies to accurately determine the percentage of TdT+ cells that were thymocyte progenitors or the percentage ofthymocyte progenitors that were TdT+. Such information would permit moreprecise analyses of the early stages of T-cell development and of the possible role of thymic factors in this process.
We have used double immunofluorescence to simultaneously assay for TdT and Lyt antigens in or on hemopoietic cells from normal (nu/+) and athymic (nu/nu) mice. The results suggest that both of these markers can be induced by brief in vitro incubation with thymosin (fraction 5 and thymosin al).
MATERIALS AND METHODS
Animals. Three-to 6-week-old C57BL/6 female athymic (nu/ nu) (Lyt-1.2+, 2.2+, 3.2+) mice and their normal (nu/+) littermates were obtained from the colonies of the Naval Medical Research Institute and the Division of Animal Resources, National Institutes of Health, Bethesda, MD. Female C57BL/ 6-Lyla (Lyt-1.1+, 2.2+, 3.2+) and C57BL/6-Ly2a3a (Lyt-1.2+, 2.1+, 3. V) strains of mice were obtained from the Jackson Laboratory.
Thymosin Preparations. The partially purified calf thymosin fraction 5 and the synthetic thymosin a1 peptide (Mr 3108) were prepared by Hoffmann-La Roche as described (13) (14) (15) . The known biological properties of these substances have been discussed elsewhere (16) . A control spleen extract (spleen fraction 5) was prepared according to the protocol for thymosin fraction 5. Antisera. Mouse alloantisera to Lyt-1.1, 1.2, 2.1, 2.2, 3.1, and 3.2 antigens were prepared according to the method ofShen et al. (17) and were absorbed with thymocytes from Lyt congeneic mice to ensure specificity and to remove autoantibodies and antiviral antibodies (18) .
An F(ab')2 fraction of rabbit antiserum to homogenous calf terminal deoxynucleotidyl transferase (anti-TdT) was rendered highly specific by elution from a terminal transferase immunoabsorbant column (3, 4, 19) . Rhodamine-conjugated goat IgG against mouse IgG, and fluorescein-conjugated goat IgG against rabbit IgG, were obtained from Cappel Laboratories (Dowingtown, PA). The former antiserum was absorbed with mouse erythrocytes before use, and the latter was purified on a normal mouse serum affmity column (10 mg/ml coupled to CNBr-activated Sepharose 4B) to remove crossreacting antibodies to mouse Ig.
Medium. The medium used was RPMI-1640 supplemented with penicillin, streptomycin, L-glutamine, and 25 mM Hepes at pH 7.4. Treatment ofCell Suspensions. Bone marrow and spleen cell suspensions were separated into four fractions by discontinuous bovine serum albumin density-gradient centrifugation as de- 
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The publication costs ofthis article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact. scribed (18) . Aliquots containing 2 X 106 cells were taken from each fraction and from the unfractionated control and incubated with either thymosin fraction 5 at 10 ug/ml, thymosin a, at 1 ,ug/ml, or spleen fraction 5 at 10 Ag/ml for 3 hr at 370C (18) .
(In preliminary experiments, these concentrations had been found to be optimal for inducing TdT and Lyt antigens.) After incubation, the cell samples were washed twice and divided into two portions, one of which was assayed for Lyt antigens by cytotoxicity (20) and the other of which was frozen in 7.5% dimethyl sulfoxide/10% fetal calf serum (21) (Fig. 1A) . In contrast, TdT+ cells in thymosin-treated suspensions showed a marked heterogeneity of fluorescence patterns, including cytoplasmic, mixed nuclear and cytoplasmic, and nuclear "ring" patterns ( Fig. 1  B-D) . These latter patterns are ordinarly restricted to cortical thymocytes (4, 5) . A greater degree of heterogeneity was displayed by thymosin-treated cells from normal mice than from athymic mice; the mixed nuclear-cytoplasmic patterns predom- Values were determined as in Table 2 . Fractions A-D were as given in Table 1 . Results represent the difference in number of Lyt' cells in aliquots of thymosin-treated and spleen fraction 5-treated cells (see Table 2 ) and are expressed as mean ± SEM of the percentage of total cells per fraction.
* Acquired phenotype in all groups: Ly-1+2+3' (>95%).
cells are thymocyte progenitors. In this respect, our results are consistent with those of Silverstone et al. (9, 10) , who used thymopoietin to induce Thy-i antigen on TdT' cells. However, the results differ in two major aspects. First, thymosin, apparently unlike thymopoietin, can induce a subset of prothymocytes to express TdT. Second, thymosin can induce TdT' cells from nu/ nu mouse bone marrow to express T-cell alloantigens. The simplest explanation for these discrepancies, aside from methodological differences, is that thymosin can stimulate TdT+ prothymocytes earlier in their development than can thymopoietin. Thus, three thymosin-responsive stages in the differentiation of TdT+ prothymocytes can be envisioned: (i) pre-TdT+ cells, (ii) early TdT+ cells, and (iii) late TdT+ cells. The last of these is presumed to give rise to TdT+ thymocytes. Pazmino et al. (11) have shown that TdT activity in normal mouse bone marrow decreases progressively after thymectomy and that low TdT levels in thymectomized and in nu/nu mice can be restored to normal by adminstration of thymosin in vivo or in vitro. Our results suggest that most of this increase in enzyme activity is due to the induction of TdT+ cells from TdTprecursors.
Our results further suggest that the thymus influences both the commitment ofearly thymocyte progenitors to the TdT cell pathway and their subsequent differentiation. However, the thymus does not seem to influence the rate at which early thy- mocyte progenitors are generated from presumptive lymphoid stem cells. Thus, nu/nu and nu/ + mice had roughly equal percentages of thymocyte progenitors (--8% of hemopoietic cells); yet, only 19% of thymocyte progenitors from athymic mouse bone marrow were TdT' after thymosin treatment as compared with 80% of thymocyte progenitors from normal mice. Moreover, most TdT' Lyt+ cells from athymic mice had a "bone marrow" pattern of TdT fluorescence whereas those from normal mice had a "thymic" pattern.
An arrest in the generation ofTdT' cells also occurs in spleen of normal postpubertal mice (5) . This appears to be due to an age-related decrease in pre-TdT' prothymocytes (see Table 5 ). Hence, the spleen may serve as a repository for TdT-prothymocytes in adult mice and bone marrow may serve as a repository for TdT' prothymocytes (22) .
The ability of thymosin to induce prethymic cells to differentiate along two different pathways, TdT' and TdT-, raises the intriguing possibility that separate progenitors exist for major thymocyte subsets-perhaps for cortical and medullary thymocytes. This hypothesis is consistant with the observations (i) that most cortical thymocytes in rats and mice are TdT' whereas medullary thymocytes are TdT-(2-5), (ii) that cortical and medullary thymocytes have independent generative ki- ' (25) (26) (27) (28) . It is also consistent with the, observation of independent homing of lymphoid stem cellsto cortex and medulla of avian thymus (F. Jotereau, personal communication) and with the selective regeneration ofTdT-thymocytes in mice depleted ofTdT' hemopoietic cells by low dose irradiation (29) . We have recently identified two proliferating populations of low Thy-l+, high H-2+ thymocytes, one of which is TdT+ and resides in the cortex and the other of which is TdT-and resides in the medulla (unpublished results). It is tempting to speculate that these two subsets of thymocytes are the immediate descendants of TdT+ and TdT-thymocyte progenitors, respectively.
It could be argued that the appearance of TdT-Lyt' cells after thymosin treatment reflects incomplete induction of TdT or that the TdT-Lyt+ cells may have transiently expressed TdT during the 3-hr incubation period. Neither argument seems probable. Both the concentration of thymosin and the incubation time were optimal for the induction of TdT and Lyt antigens. Under these conditions, TdT specific activity and percent Lyt+ cells (14, 16) increase linearly during the first 3-4 hr of incubation and then remain constant for at least 20 hr. It must be noted that the reported inability of thymosin a, to induce TdT in vitro (12) Fig. 3 . In this scheme, the TdT' and TdT-lineages ofprothymocytes are postulated to arise from a common TdT-ancestor. The proportion of prothymocytes committed to the TdT' or TdT-lineage is influenced by a combination of long-range (thymic) and shortrange (microenvironmental) interactions. Mature ("late") prothymocytes migrate to the thymus, where they undergo further differentiation. The anticipated result of this developmental process is the production of two independent lineages of thymocytes and, ultimately, of T cells.
